EP Patent

EP3827747A1 — Pharma-informatics system

Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2021-06-02 · 5y expired

What this patent protects

A system comprising: an active agent; a pharmaceutically acceptable carrier; a signal generation component for emitting a current, the signal generation component comprising: a circuitry layer on a silicon support layer; an anode layer comprising a metal material electrically cou…

USPTO Abstract

A system comprising: an active agent; a pharmaceutically acceptable carrier; a signal generation component for emitting a current, the signal generation component comprising: a circuitry layer on a silicon support layer; an anode layer comprising a metal material electrically coupled to the circuitry layer; and a cathode layer comprising a salt material electrically coupled to the circuitry layer and electrically isolated from the anode layer; wherein the anode layer and the cathode layer are made from different materials selected to provide a voltage potential difference as a result of the materials being in contact with a conducting liquid to power the signal generation component, wherein the circuitry layer and the silicon support layer are positioned between the anode and cathode layers; wherein the circuitry layer is configured to produce in the conducting liquid a current between the anode layer and the cathode layer; an activation component configured to activate the signal generation component to generate the current through the conducting liquid; and a receiver configured to remotely detect the emitted current.

Drugs covered by this patent

Patent Metadata

Patent number
EP3827747A1
Jurisdiction
EP
Classification
Expires
2021-06-02
Drug substance claim
No
Drug product claim
No
Assignee
Otsuka Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.